Active Ingredient History

NOW
  • Now
Veliparib (ABT-888) is a potential anti-cancer drug acting as a PARP inhibitor. It kills cancer cells by blocking a protein called PARP, thereby preventing the repair of DNA or genetic damage in cancer cells and possibly making them more susceptible to anticancer treatments. Veliparib may make whole brain radiation treatment work more effectively against brain metastases from NSCLC. It has been shown to potentiate the effects of many chemotherapeutics, and as such has been part of many combination clinical trials.   Wikipedia

  • SMILES: C[C@@]1(CCCN1)c2nc3cccc(C(=O)N)c3[nH]2
  • InChIKey: JNAHVYVRKWKWKQ-CYBMUJFWSA-N
  • Mol. Mass: 244.3
  • ALogP: 1.26
  • ChEMBL Molecule:
More Chemistry
2-(2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide | 2-((2r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide | (2r)-2-(7-carbamoyl-1h-benzimidazol-2-yl)-2-methylpyrrolidinium | 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide | abt888 | abt 888 | abt-888 | veliparib

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue